Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.05%	0.05%	Drops	181,419 L.L
G03CA03	OESTRODOSE	B	Estradiol (17 bêta estradiol anhydre) - 0.06%	0.06%	Gel	642,357 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.1%	0.1%	Solution	260,705 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.1%	0.1%	Drops	241,892 L.L
R01AA07	OTRIVIN MENTHOL 0.1%	B	Xylometazoline HCl - 0.1%	0.1%	Drops	387,027 L.L
S01BA07	OPTILONE	G	Fluorometholone - 0.1%	0.1%	Solution	309,084 L.L
S01GX09	OLOHISTINE	G	Olopatadine (HCl) - 0.1%	0.1%	Solution	522,755 L.L
S01GX09	OLOPAT	G	Olopatadine (HCl) - 0.1%	0.1%	Drops solution	524,099 L.L
S01GX09	OLOPAT UD	G	Olopatadine (HCl) - 0.1%	0.1%	Drops solution	1,523,917 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 0.25mcg	0.25mcg	Capsule	1,138,235 L.L
A10BJ06	OZEMPIC	B	Semaglutide - 0.25mg	0.25mg	Injectable solution	10,927,526 L.L
H01CC01	ORGALUTRAN	B	Ganirelix - 0.25mg/0.5ml	0.25mg/0.5ml	Injectable solution	2,383,977 L.L
H01CC01	ORGALUTRAN	B	Ganirelix - 0.25mg/0.5ml	0.25mg/0.5ml	Injectable solution	2,383,977 L.L
S01AE01	OFLOX	B	Ofloxacin - 3mg/ml	0.3%	Drops solution	366,869 L.L
S01AE01	OFLOX	B	Ofloxacin - 0.3%	0.3%	Drops solution	366,869 L.L
R06AD08	OXOMIL	G	Oxomemazine HCl - 0.33mg/ml	0.33mg/ml	Syrup, sugar free	511,940 L.L
R06AD08	OXOMEMAZINE ARROW	G	Oxomemazine HCl - 0.33mg/ml	0.33mg/ml	Syrup	431,373 L.L
R06AD08	OXOMEMAZINE ARROW	G	Oxomemazine HCl - 0.33mg/ml	0.33mg/ml	Solution, sugar free	431,373 L.L
G04CA02	OMNIC OCAS	B	Tamsulosin HCl - 0.4mg	0.4mg	Tablet, film coated, prolonged release	866,778 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 0.5mcg	0.5mcg	Capsule	943,377 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 0.5mcg	0.5mcg	Capsule	942,034 L.L
A10BJ06	OZEMPIC	B	Semaglutide - 0.5mg	0.5mg	Injectable solution	10,927,526 L.L
R06AX27	ORADUS	G	Desloratadine - 0.5mg/ml	0.5mg/ml	Solution	199,657 L.L
G03CA03	OESTRACLIN	G	Estradiol - 0.6mg/g	0.6mg/g	Gel	448,843 L.L
S01AA13	OPTIFUCIN VISCOUS	G	Fusidic acid - 1%	1%	Drops	208,296 L.L
M02AA15	OLFEN	G	Diclofenac sodium (diethylamine) - 1%	1%	Gel	268,769 L.L
B02BD02	OCTANATE	BioHuman	Coagulation Factor VIII - 1,000IU	1,000IU	Injectable lyophilised powder for solution+diluent	46,817,511 L.L
J01CA04	OSPAMOX	G	Amoxicillin (trihydrate) - 1g	1,000mg	Tablet, film coated	683,273 L.L
A11CC05	ONE BIG-D 10.000	G	Vitamin D3 - 10,000IU	10,000IU	Capsule	895,895 L.L
A11CC05	ORAVIL	G	Vitamin D3 - 100,000IU/2ml	100,000IU	Solution	618,168 L.L

...